These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 21622768

  • 1. Adipokine profile is modulated in subcutaneous adipose tissue by TNFα inhibitors in patients with rheumatoid arthritis.
    Šenolt L, Kuklová M, Cerezo LA, Hulejová H, Filková M, Bošanská L, Pecha O, Pavelka K, Haluzík M, Vencovský J.
    Ann Rheum Dis; 2011 Nov; 70(11):2054-6. PubMed ID: 21622768
    [No Abstract] [Full Text] [Related]

  • 2. [TNFalpha inhibitors for the treatment of rheumatoid arthritis].
    Sany J, Kaiser MJ.
    Ann Med Interne (Paris); 2002 Feb; 153(1):34-40. PubMed ID: 11994688
    [Abstract] [Full Text] [Related]

  • 3. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
    Favalli EG, Arreghini M, Arnoldi C, Panni B, Marchesoni A, Tosi S, Pontikaki I.
    Arthritis Rheum; 2004 Apr 15; 51(2):301-2. PubMed ID: 15077278
    [No Abstract] [Full Text] [Related]

  • 4. The role of tumor necrosis factor inhibitors in patients with RA.
    Trethewey P.
    JAAPA; 2002 Sep 15; 15(9):23-4, 27, 30 passim. PubMed ID: 12395668
    [No Abstract] [Full Text] [Related]

  • 5. Lessons from magnetic resonance imaging studies in rheumatoid arthritis.
    Quinn M.
    J Rheumatol; 2008 Mar 15; 35(3):372-4. PubMed ID: 18322971
    [No Abstract] [Full Text] [Related]

  • 6. Etanercept (Enbrel) -- an update.
    Goffe B.
    Skin Therapy Lett; 2008 Mar 15; 9(10):1-4, 9. PubMed ID: 15657632
    [Abstract] [Full Text] [Related]

  • 7. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
    Koumakis E, Wipff J, Avouac J, Kahan A, Allanore Y.
    J Rheumatol; 2009 Sep 15; 36(9):2125-6. PubMed ID: 19738227
    [No Abstract] [Full Text] [Related]

  • 8. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Cytokine antagonists].
    Schnabel A, Gross WL.
    Dtsch Med Wochenschr; 2003 Jan 31; 128(5):201-3. PubMed ID: 12557112
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fcgamma receptor type IIIA genotype and response to tumor necrosis factor alpha-blocking agents in patients with rheumatoid arthritis.
    Kastbom A, Bratt J, Ernestam S, Lampa J, Padyukov L, Söderkvist P, Skogh T.
    Arthritis Rheum; 2007 Feb 31; 56(2):448-52. PubMed ID: 17265480
    [Abstract] [Full Text] [Related]

  • 12. Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis.
    Nagashima T, Okubo-Fornbacher H, Aoki Y, Kamata Y, Kimura H, Kamimura T, Nara H, Iwamoto M, Yoshio T, Okazaki H, Minota S.
    J Rheumatol; 2008 May 31; 35(5):936-8. PubMed ID: 18464318
    [No Abstract] [Full Text] [Related]

  • 13. Assessing the value of rheumatoid arthritis treatment alternatives: the potential effect of tumor necrosis factor inhibitors.
    Mizutani W.
    Manag Care Interface; 2003 Mar 31; 16(3):44-50, 55. PubMed ID: 12715413
    [Abstract] [Full Text] [Related]

  • 14. [Stable remission of early active rheumatoid arthritis treated with etanercept (Enbrel)].
    Kaliterna DM.
    Reumatizam; 2008 Mar 31; 55(2):60-1. PubMed ID: 19024277
    [Abstract] [Full Text] [Related]

  • 15. Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.
    Catrina AI, af Klint E, Ernestam S, Catrina SB, Makrygiannakis D, Botusan IR, Klareskog L, Ulfgren AK.
    Arthritis Rheum; 2006 Jan 31; 54(1):76-81. PubMed ID: 16385498
    [Abstract] [Full Text] [Related]

  • 16. Perforating folliculitis associated with tumour necrosis factor-alpha inhibitors administered for rheumatoid arthritis.
    Gilaberte Y, Coscojuela C, Vázquez C, Roselló R, Vera J.
    Br J Dermatol; 2007 Feb 31; 156(2):368-71. PubMed ID: 17223880
    [Abstract] [Full Text] [Related]

  • 17. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept.
    Kekow J, Welte T, Kellner U, Pap T.
    Arthritis Rheum; 2002 Mar 31; 46(3):843-4. PubMed ID: 11920425
    [No Abstract] [Full Text] [Related]

  • 18. Anti-tumour necrosis factor therapy in the West Midlands.
    Bartram D, Sheeran T, Price T, Mulherin D.
    Rheumatology (Oxford); 2004 Mar 31; 43(3):400; author reply 400-1. PubMed ID: 14963219
    [No Abstract] [Full Text] [Related]

  • 19. Rheumatoid arthritis.
    Ramsburg KL.
    Am J Nurs; 2000 Nov 31; 100(11):40-3. PubMed ID: 11103634
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.